Caffeine Completed Phase 3 Trials for Primary apnea of premature newborns Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00182312Caffeine for Apnea of Prematurity (CAP)